Flavone acetic acid stimulates nitric oxide and peroxynitrite production in subcutaneous mouse tumors

Biochemical and Biophysical Research Communications

Volumn 235, Issue 3, 1997, Pages 509-514

  Harris, Steven R ^a   Thorgeirsson, Unnur P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM ION; MITOFLAXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR CELL; TUMOR VASCULARIZATION;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0031587936     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.6820     Document Type: Article

References (20)

1. Bibby M. C., Double J. A. Anti-Cancer Drugs. 4:1993;3-17.
2. Cummings J., Smyth J. F. Cancer Chemother. Pharmacol. 24:1989;269-272.
3. Graeme J. F., Geoffrey P. S., Linley M. F., Baguley B. C. J. Natl. Cancer Inst. 80:1988;241-245.
4. Futami H., Eader L. A., Komschlies K. L., Bull R., Gruys M. E., Ortaldo J. R., Young H. A., Wiltrout R. H. Cancer Res. 51:1991;6596-6602.
5. Philpott M., Baguley B. C., Ching L. Cancer Chemother. Pharmacol. 36:1995;143-148.
6. Ching L., Xu Z., Gummer B. H., Palmer B. D., Joseph W. R., Baguley B. C. Br. J. Cancer. 72:1995;339-343.
7. Zwi L. J., Baguley B. C., Gavin J. B., Wilson W. R. Br. J. Cancer. 62:1990;231-237.
8. Mahadevan V., Hart I. R. Br. J. Cancer. 63:1991;889-892.
9. Thomsen L. L., Ching L., Baguley B. C. Cancer Res. 50:1990;6966-6970.
10. Thomsen L. L., Ching L., Zhuang L., Gavin J. B., Baguley B. C. Cancer Res. 51:1991;77-81.
11. Hampton L. L., Worland P. J., Yu B., Thorgeirsson S. S., Huggett A. C. Cancer Res. 50:1990;7460-7467.
12. Huggett A. C., Hampton L. L., Ford C. P., Wirth P. J., Thorgeirsson S. S. Cancer Res. 50:1990;7468-7475.
13. Brooks P. C., Montgomery A. M. P., Rosenfeld M., Reisfeld R. A., Hu T., Klier G., Cheresh D. A. Cell. 79:1994;1157-1164.
14. Futami H., Eader L. A., Back T. T., Gruys E., Young H. A., Wiltrout R. H., Baguley B. C. J. Immunother. 12:1992;247-255.
15. Gerritsen M. E., Bloor C. M. FASEB J. 7:1993;523-532.
16. Szabo C., Salzman A. L., Ischiropoulos H. FEBS Lett. 372:1995;229-232.
17. Lin K., Xue J., Nomen M., Spur B., Wong P. Y. J. Biol. Chem. 270:1995;16487-16490.
18. Salgo M. G., Squadrito G. L., Pryor W. A. Biochem. Biophys. Res. Commun. 215:1995;1111-1118.
19. White C. R., Brock T. A., Chang L. Y., Crapo J., Briscoe P., Ku D., Bradley W., Gianturco S., Gore J., Freeman B., Tarpey M. Proc. Natl. Acad. Sci. USA. 91:1994;1044-1048.
20. Haddad I. Y., Pataki G., Hu P., Galliani C., Beckman J. S., Matalon S. J. Clin. Invest. 94:1994;2407-2413.